Equities Analysts Offer Predictions for IINN FY2025 Earnings

Inspira Technologies OXY B.H.N. Ltd. (NASDAQ:IINN) – Stock analysts at Litchfield Hills Research decreased their FY2025 EPS estimates for Inspira Technologies OXY B.H.N. in a research report issued to clients and investors on Thursday, January 8th. Litchfield Hills Research analyst T. O’neill now anticipates that the company will earn ($0.44) per share for the year, down from their previous forecast of ($0.42).

Other analysts have also recently issued reports about the company. Weiss Ratings reissued a “sell (d-)” rating on shares of Inspira Technologies OXY B.H.N. in a report on Monday, December 29th. Wall Street Zen upgraded Inspira Technologies OXY B.H.N. from a “sell” rating to a “hold” rating in a research report on Sunday, October 26th. One equities research analyst has rated the stock with a Buy rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, Inspira Technologies OXY B.H.N. currently has an average rating of “Hold” and an average target price of $2.00.

Inspira Technologies OXY B.H.N. Stock Performance

Shares of IINN opened at $0.93 on Monday. The company has a quick ratio of 0.90, a current ratio of 1.15 and a debt-to-equity ratio of 0.27. The stock’s 50 day moving average is $1.00 and its two-hundred day moving average is $1.14. Inspira Technologies OXY B.H.N. has a twelve month low of $0.40 and a twelve month high of $1.65.

Institutional Trading of Inspira Technologies OXY B.H.N.

An institutional investor recently bought a new position in Inspira Technologies OXY B.H.N. stock. Citadel Advisors LLC bought a new stake in Inspira Technologies OXY B.H.N. Ltd. (NASDAQ:IINN) during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 82,567 shares of the company’s stock, valued at approximately $105,000. Citadel Advisors LLC owned about 0.65% of Inspira Technologies OXY B.H.N. as of its most recent filing with the Securities & Exchange Commission. 12.72% of the stock is owned by hedge funds and other institutional investors.

About Inspira Technologies OXY B.H.N.

Inspira Technologies Oxy B.H.N. Ltd., a specialty medical device company, engages in the research, development, manufacture, and marketing of respiratory support technology to provide an alternative to invasive mechanical ventilation for the treatment of acute respiratory failure. Its lead product is the augmented respiration technology system, a respiratory support system comprising minimally invasive, portable dual lumen cannula, which is inserted into the jugular vein and utilizes extra-corporeal direct blood oxygenation to elevate and stabilize declining oxygen saturation levels.